To determine whether the up-regulation of HSP90 accounts for HDAC6 stabilization and thus its overexpression in PAH-PASMCs, pharmacological inhibition of HSP90 activity with AT13387 or 17-AAG or siRNA-mediated knockdown of HSP90 was performed. The gene discussed is HDAC6; the disease is pulmonary arterial hypertension.